kurnool NTR

లక్షణాలు నయమయ్యాకా కరోనా వైరస్‌ ఉండొచ్చు! బీజింగ్‌: కొవిడ్‌-19 లక్షణాలు కనిపించడం మానేశాక వారిలో వైరస్‌ ఉంటుందా? అది ఇతరులకు వ్యాపిస్తుందా? అనే సందేహాలు చాలామందికి ఉన్నాయి. అమెరికాలోని యేల్‌ విశ్వవిద్యాలయం పరిశోధకులు వీటికి వివరణ ఇచ్చేందుకు ప్రయత్నించారు. కరోనా లక్షణాలు స్వల్పంగా ఉండి తగ్గిపోయాక ఎనిమిది రోజుల వరకు వారిలో వైరస్‌ ఉంటుందని అంటున్నారు. అందుకే ఈ మహమ్మారి వ్యాప్తిని నియంత్రించడం కష్టమవుతోందని వెల్లడిస్తున్నారు. బీజింగ్‌లోని పీఎల్‌ఏ జనరల్‌ ఆస్పత్రిలో 2020 జనవరి 28 నుంచి ఫిబ్రవరి 9 వరకు చికిత్స పొందిన 16 మందిపై పరిశోధన చేసిన శాస్త్రవేత్తలు అమెరికా జర్నల్‌ ఆఫ్‌ రెస్పిరేటరీ, క్రిటికల్‌ కేర్‌ మెడిసిన్‌లో ప్రచురించారు. ఈ అధ్యయనంలో భారత సంతతికి చెందిన శాస్త్రవేత్త లోకేశ్‌ శర్మ సైతం పాలు పంచుకున్నారు. పరీక్షల్లో రెండుసార్లు నెగెటివ్‌ వచ్చిన రోగుల గొంతుల్లోంచి నమూనాలను పరిశోధకులు రోజు విడిచి రోజు సేకరించారు. ‘రోగుల్లో సగం మందికి లక్షణాలు తగ్గాక కూడా వైరస్‌ కణాలు ఉంటున్నాయని మా అధ్యయనంలో తేలింది. తీవ్ర లక్షణాలు ఉన్న వారిలో ఇంకాస్త ఎక్కువ రోజులే ఉంటాయి. జ్వరం, దగ్గు, గొంతునొప్పి, శ్వాస కష్టమైన వారి నమూనాలే సేకరించాం. ఎక్కువ మందిలో ఐదు రోజుల్లో లక్షణాలు కనిపిస్తే ఒక్కరిలో మాత్రం ఎనిమిది రోజులకు లక్షణాలు గుర్తించాం’ అని లోకేశ్‌ శర్మ తెలిపారు. కరోనా లక్షణాలు కనిపించడం మానేసిన ఒకటి నుంచి ఎనిమిది రోజుల వరకు వారి నుంచి ఇతరులకు కొవిడ్‌-19 సోకే అవకాశం ఉందని ఈ అధ్యయనంలో తేలింది. ‘కొవిడ్‌-19 స్వల్ప లక్షణాలు కనిపించిన వ్యక్తి ఇంట్లోనే క్వారంటీన్‌ అయ్యాడనుకుందాం. వారు కోలుకున్నాక మరొకరికి వైరస్‌ సంక్రమించకుండా ఉండాలంటే కనీసం రెండు వారాలు క్వారంటైన్‌ అవ్వాలి’ చైనా పీఎల్‌ఏ జనరల్‌ ఆస్పత్రి వైద్యుడు లిషిన్‌ షీ తెలిపారు. దీనిపై ఇంకా కచ్చితమైన పరిశోధనలు చేయాల్సి ఉందన్నారు. Some people can be silent spreaders. Utmost responsibility is needed at this time.

Anna canteen vundi vunte poor people could have utilised those

Current AP govt (YCP) should use those houses to quarantine people.

హైదరాబాద్‌: మద్యం లభించడం లేదని ఓ కార్మికుడు ఆత్మహత్య చేసుకోగా మరొకరు ఆత్మహత్యకు యత్నించిన వైనమిది. బంజారాహిల్స్‌, పంజాగుట్ట పోలీసుల కథనం ప్రకారం.. బంజారాహిల్స్‌ ఇందిరానగర్‌ వాసి, సినీ పరిశ్రమలో పెయింటర్‌గా పనిచేసే మధు(55)కు నిత్యం మద్యం తాగే అలవాటు ఉంది. కొన్నాళ్లుగా దుకాణాల మూసివేతతో ఇతడికి మద్యం లభించలేదు. ఈ క్రమంలో గురువారం రాత్రి ఇంటి నుంచి బయటకు వెళ్లిన మధు బంజారాహిల్స్‌ రోడ్‌-10లోని ఐఏఎస్‌, ఐపీఎస్‌ క్వార్టర్స్‌లోని బ్లాక్‌ 8 భవనం నాలుగో అంతస్థుకు వెళ్లాడు. అక్కడి నుంచి కిందకు దూకి ఆత్మహత్యకు పాల్పడ్డాడు. క్వార్టర్స్‌వారు ఉదయం గమనించి సమాచారం ఇవ్వడంతో బంజారాహిల్స్‌ పోలీసులు వచ్చారు. ఇదే రోజు.. తండ్రి కనిపించడం లేదని మధు కుమారుడు బంజారాహిల్స్‌ స్టేషన్‌కు రాగా మృతుడిని గుర్తించారు. మరో ఘటనలో.. బేగంపేట్‌ బ్రాహ్మణవాడికి చెందిన టైల్స్‌పని కార్మికుడు సాయికుమార్‌(32) కొన్ని రోజులుగా మద్యం దొరకని నేపథ్యంలో శుక్రవారం పంజాగుట్ట కూడలిలోని రెండు పైవంతెనల మధ్య దూకి ఆత్మహత్యకు ప్రయత్నించాడు. కాలు విరిగిన అతడిని పోలీసులు ఉస్మానియా ఆస్పత్రికి తరలించారు. అడ్మిన్‌ ఎస్‌ఐ చంద్రశేఖర్‌ కేసు దర్యాప్తు చేస్తున్నారు.

65 million people were killed in this simulation

They did this Pandemic simulation 2 months before the outbreak. Pandemic simulation exercise spotlights massive preparedness gap Event 201, hosted by the Johns Hopkins Center for Health Security, envisions a fast-spreading coronavirus with a devastating impact ByKatie Pearce / Published Nov 6, 2019 Back in 2001, it was a smallpox outbreak, set off by terrorists in U.S. shopping malls. This fall, it was a SARS-like virus, germinating quietly among xxx farms in Brazil before spreading to every country in the world. With each fictional pandemic Johns Hopkins experts have designed, the takeaway lesson is the same: We are nowhere near prepared. "Once you're in the midst of a severe pandemic, your options are very limited," says Eric Toner, a senior scholar at the Center for Health Security at Johns Hopkins University. "The greatest good can happen with pre-planning." "ONCE YOU'RE IN THE MIDST OF A SEVERE PANDEMIC, YOUR OPTIONS ARE VERY LIMITED. THE GREATEST GOOD CAN HAPPEN WITH PRE-PLANNING." Eric Toner Senior scholar, Johns Hopkins Center for Health Security That center's latest pandemic simulation, Event 201, dropped participants right in the midst of an uncontrolled coronavirus outbreak that was spreading like wildfire out of South America to wreak worldwide havoc. As fictional newscasters from "GNN" narrated, the immune-resistant virus (nicknamed CAPS) was crippling trade and travel, sending the global economy into freefall. Social media was rampant with rumors and misinformation, governments were collapsing, and citizens were revolting. For those participating in New York City on Oct. 18—a heavyweight group of policymakers, business leaders, and health officials—Event 201 was a chance to see how much catch-up work is needed to bolster our disaster response systems. Full videos of the discussion are available online. "It really does shake up assumptions and change thinking about how we can prepare for a global pandemic," says Tom Inglesby, director of the Center for Health Security. VIDEO CREDIT: JOHNS HOPKINS CENTER FOR HEALTH SECURITY Event 201 is the fourth such exercise hosted by the Johns Hopkins center, which works to prepare communities for biological threats, pandemics, and other disasters. The simulations started with 2001's Dark Winter, which gathered national security experts for its simulated smallpox outbreak. The groundbreaking event turned out to be influential in shaping U.S. efforts around pandemic preparedness—particularly due to its timing, right before 9/11. "Dark Winter resulted in more than a dozen congressional hearings, was briefed to the White House, and ultimately influenced the decision to stockpile enough smallpox vaccine for all Americans," Inglesby says. That simulation and its two successors—Atlantic Storm, conducted in 2005, and last summer's Clade X—have also demonstrated lasting value as educational and advocacy tools, with reenactments or modified versions taking place in settings including universities, the CDC, and Capitol Hill, according to Inglesby. "These exercises have a long fuse," he says. For Event 201, hosted in collaboration with the World Economic Forum and the Bill & Melinda Gates Foundation, the experts added a new layer of realism by reaching beyond government and NGOs to leaders in the private sector and business community. Participants included representatives from NBCUniversal, UPS, and Johnson & Johnson. "Very few people have included the private sector in pandemic preparedness, but that's where most of the resources are," Toner says. That's particularly true when it comes to vaccine development. The CAPS virus—which Toner describes as a cousin of SARS, "but slightly more transmissible, like the flu, and slightly more lethal"—was presented as resistant to any existing vaccine, as scientists scrambled to come up with one. Citizens, meanwhile, were rioting over scarce access to the next best thing: a fictional antiviral known to treat some CAPS symptoms. That scenario, Toner says, is utterly realistic. "We don't have a vaccine for SARS, or MERS, or various avian flu viruses that have come up in the past decade," he notes. "That's because vaccine development is slow and difficult if there isn't an immediate market for it." In the simulation, CAPS resulted in a death toll of 65 million people within 18 months—surpassing the deadliest pandemic in history, the 1918 Spanish flu. From the discussions Event 201 inspired, the Center for Health Security plans to release a set of formal recommendations within the coming weeks. Shortly after the simulation, the center released the Global Health Security Index, the first-ever comprehensive ranking of countries on their pandemic preparedness. All in all, the picture was discouraging: The average score, across 195 countries, was 40 out of a possible 100. "It's our hope," Inglesby says, "that countries will use this to consider where they are strong and where they are weak." https://hub.jhu.edu/2019/11/06/event-201-health-security/

Nice message BTW people are enjoying Jagan's speeches, this circulation should not be stopped.

Veedu Masjid ki velli inkonthamandiki spread chesi vundochu

Hilarious 🤣

The thought of destruction is a signalling from environment. It is destined to be destroyed for the more better to evolve. The bigger program designed is to recycle everything and recreate everything

Ear, nose and throat (ENT) specialists in Britain, the U.S. and France have noted a growing number of patients in recent weeks with anosmia — the abrupt loss of Smell From a mother unable to smell her baby’s nappy to a lawmaker who suddenly could not taste food, some COVID-19 patients have described a loss of olfactory senses — and experts say this might be a new way to detect the virus. The World Health Organisation lists the most common signs of COVID-19 as fever, tiredness and dry cough. In Britain, ENT doctors have urged health authorities to advise people with a sudden loss of smell or taste to self-isolate even if they have no other symptoms. “Anything we can do to delay transmission is absolutely vital,” Claire Hopkins, the president of the British Rhinological Society, told AFP. Ms. Hopkins, who published an open letter on the issue on Friday with ENT U.K. chief Nirmal Kumar, said she was not surprised when she heard initial reports from Iran and France of COVID-19 patients reporting a loss of smell. Around 40% of cases of sudden loss of smell in adults are caused by post-viral anosmia, she said.

Clinical trials are still going on

Evidence only anecdotal, expert said Regarding the combination of hydroxychloroquine and the antibiotic azithromycin -- which Trump tweeted could be "one of the biggest game changers in the history of medicine" -- a single "small study" shows the combination helped against the SARS strain that causes Covid-19, the CDC said, but "did not assess clinical benefits." The CDC said the combination can disrupt the heart's electrical activity and warns against prescribing the paired drugs to anyone with chronic medical conditions, such as renal failure or hepatic disease. Chloroquine's side effects include seizures, nausea, vomiting, deafness, vision changes and low blood pressure. Both chloroquine and hydroxychloroquine, however, are reportedly well-tolerated in Covid-19 patients, according to the CDC. Loss of smell and taste could be coronavirus symptoms 01:35 All that said, Dr. Anthony Fauci, the director of National Institute of Allergy and Infectious Diseases who has appeared alongside Trump at several news conferences, has said evidence of the drugs' effectiveness is only anecdotal. With respect to the SARS strain, the drugs' effectiveness was never vetted in a clinical trial, he said. The drugs may be effective against the novel coronavirus, Fauci said, but more data is needed to "show it is truly safe and effective under the conditions of Covid-19." For these reasons, the US Food and Drug Administration has not approved the drugs for coronavirus treatment, despite Trump claiming Thursday the agency had done so. 'It showed promise in the test tubes' In a Thursday statement, the FDA said it had been working with government agencies and universities to learn whether chloroquine can reduce symptoms and stem the spread of Covid-19 in those with mild to moderate cases of the virus. "We also must ensure these products are effective; otherwise we risk treating patients with a product that might not work when they could have pursued other, more appropriate treatments," FDA Commissioner Stephen Hahn said in the statement. During a meeting of the coronavirus task force, Hahn called for "a large, pragmatic clinical trial to actually gather that information and answer the question that needs to be answered -- asked and answered." Inside Italian hospital on frontline of coronavirus fight 01:28 The FDA is also talking with drug manufacturers about ramping up production of the drugs to handle a spike in demand and to ensure that people with life-threatening conditions such as lupus can still obtain it. Dr. Deborah Birx, Vice President Mike Pence's coronavirus response coordinator and another regular at Trump's news conferences, said in a Fox News interview last week that people should not confuse the drugs showing "promise" in other countries with actual efficacy. "That doesn't mean that it will show promise in Americans," she told the news outlet. "It showed promise in the test tubes. We are very interested in making sure we have eliminated red tape to make the drug available through their physicians, and study it at the same time. At the same time, we are doing clinical trials on other products we think also will show promise." One drug, lopinavir-ritonavir, did not show promise for treating Covid-19-related pneumonia in China, the CDC said. Another medication mentioned by Trump, remdesivir, has "broad antiviral activity," the CDC said, but requires further study. https://www.cnn.com/2020/03/23/health/chloroquine-hydroxycholoroquine-drugs-explained/index.html

nijame anukunta https://timesofindia.indiatimes.com/city/hyderabad/Charity-City-may-be-on-assigned-land/articleshow/2112119.cms

Research is still going on. Do no spread this news, people can be at danger.